Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination

GLIA

Volumn 62, Issue 2, 2014, Pages 284-299

  Pusic, Aya D ^a   Kraig, Richard P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Aging; Hippocampal slice culture; Multiple sclerosis; Neuroimmune; Remyelination

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE; MESSENGER RNA; MICRORNA; MICRORNA 128; MICRORNA 138; MICRORNA 145; MICRORNA 184; MICRORNA 199A 5P; MICRORNA 19B; MICRORNA 219; MICRORNA 219 1 3P; MICRORNA 219 2 3P; MICRORNA 219 5P; MICRORNA 23A; MICRORNA 23B; MICRORNA 338; MICRORNA 9; MYELIN; UNCLASSIFIED DRUG;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; DENTATE GYRUS; ENVIRONMENTAL ENRICHMENT; EXOSOME; FEMALE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; MALE; MYELINATION; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REMYELINIZATION;

AGING; HIPPOCAMPAL SLICE CULTURE; MULTIPLE SCLEROSIS; NEUROIMMUNE; REMYELINATION;

AGING; ANIMALS; AXONS; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASES; ENVIRONMENTAL EXPOSURE; EXOSOMES; MALE; MICRORNAS; MYELIN SHEATH; NEURAL STEM CELLS; OLIGODENDROGLIA; RATS, INBRED WKY;

EID: 84890164626     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22606     Document Type: Article

References (74)

1. Aharoni R, Herschkovitz RE, Blumberg-Hazan M, Sela M, Bruck W, Arnon R. 2008. Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 105:11358-11363.
2. Alvarez-Erviti L, Seog Y, Yin H, Betts C, Lakhal S, Wood MJ. 2011. Delivery of siRNA to brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341-345.
3. Amato MP, Zipoli V, Portaccio E. 2006. Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies. J Neurol Sci 245:41-46.
4. Baracskay KL, Kidd GJ, Miller RH, Trapp BD. 2007. NG2-positive cells generate A2B5-positive oligodendrocyte precursor cells. Glia 55:1001-1010.
5. Baron-Van Evercooren A, Avellana-Adalid V, Ben Younes-Chennoufi A, Gansmuller A, Nait-Oumesmar B, Vignais L. 1996. Cell-cell interactions during the migration of myelin-forming cells transplanted in the demyelinated spinal cord. Glia 16:147-164.
6. Barres BA, Schmid R, Sendnter M, Raff MC. 1993. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118:283-295.
7. Barres BA, Lazar MA, Raff MC. 1994. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 120:1097-1108.
8. Bartel DP. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136:215-233.
9. Baumann N, Pham-Dinh D. 2010. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871-927.
10. Birgbauer E, Rao TS, Webb M. 2004. Lysolecithin induces demyelination in vitro in a cerebellar slice culture system. J Neurosci Res 78:157-166.
11. Bobrie A, Colombo M, Raposo G, Thery C. 2011. Exosome secretion: Molecular mechanisms and roles in immune responses. Traffic 12:1659-1668.
12. Brewer GJ, Torricelli JR, Evege EK, Price PJ. 1993. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res 35:567-576.
13. Bruck W, Tanja K, Stadelmann C. 2003. Remyelination in multiple sclerosis. J Neurol Sci 206:181-185.
14. Boutin C, Hardt O, de Chevigny A, Core N, Goebbels S, Seidenfaden R, Bosio A, Cremer H. 2010. NeuroD1 induces terminal neuronal differentiation in olfactory neurogenesis. Proc Natl Acad Sci USA 107:1201-1206.
15. Chang A, Tourtellotte WW, Rudick R, Trapp BD. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165-173.
16. Chen Y, Stevens B, Chang J, Milbrandt J, Barres BA, Hell JW. 2008. NS21: Re-defined and modified supplement B27 for neuronal cultures. J Neurosci Methods 171:239-247.
17. Chomiak T, Hu B. 2009. What is the optimal value of the g-ratio for myelinated fibers in the rat CNS? A theoretical approach. PLoS One 4:e7754.
18. de Faria O Jr, Cui QL, Bin JM, Bull SJ, Kennedy TE, Bar-Or A, Antel JP, Colman DR, Dhaunchak AS. 2012. Regulation of miRNA 219 and miRNA clusters 338 and 17-92 in oligodendrocytes. Front Genet 3:46.
19. De la Fuente M, Gimenez-Llort L. 2012. Models of aging of neuroimmunomodulation: Strategies for its improvement. Neuroimmunomodulation 17:213-216.
20. Dugas JC, Cuellar TL, Scholze A, Ason B, Ibrahim A, Emery B, Zamanian JL, Foo LC, McManus MT, Barres BA. 2010. Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination. Neuron 65:597-611.
21. Ebrahimi-Barough S, Kouchesfehani HM, Ai J, Mahmoodinia M, Tavakol S, Massumi M. 2013. Programming of human endometrial-derived stromal cells (EnSCs) into pre-oligodendrocyte cells by overexpression of miR-219. Neurosci Lett 537:65-70.
22. El Andaloussi S, Lakhal S, Mager I, Wood MJ. 2012. Exosomes for targeted siRNA delivery across biological barriers. Adv Drug Deliv Rev 65:391-397.
23. Fares RP, Belmeguenai A, Sanchez PE, Kouchi HY, Bodennec J, Morales A, Georges B, Bonnet C, Bouvard S, Sloviter RS, Bezin L. 2013. Standardized environmental enrichment supports enhanced brain plasticity in healthy rats and prevents cognitive impairment in epileptic rats. PLoS One 8:e53888.
24. Favreau AJ, Sathyanarayana P. 2012. miR-590-5p, miR-219-5p, miR-15b and miR-628-5p are commonly regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukemia. Leuk Res 36:334-341.
25. Fredman G, Li Y, Dalli J, Chiang N, Serhan CN. 2012. Self-limited versus delayed resolution of acute inflammation: Temporal regulation of pro-resolving mediators and microRNA. Sci Rep 2:639.
26. Fruttiger M, Karlsson L, Hall AC, Abramsson A, Calver AR, Bostrom H, Willetts K, Bertold CH, Heath JK, Betsholtz C, Richardson WD. 1999. Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development 126:457-467.
27. Fields DR. 2008. White matter in learning, cognition and psychiatric disorders. Trends Neurosci 31:316-370.
28. Gahwiler BH, Capogna M, Debanne D, McKinney RA, Thompson SM. 1997. Organotypic slice cultures: A technique has come of age. Trends Neurosci 20:471-477.
29. Gallo A, Tandon M, Alevizos I, Illei GG. 2012. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 7(3):e30679.
30. Geurts JJ, Bo L, Roosendaal SD, Hazes T, Daniels R, Barkhof F, Witter MP, Huitinga I, van der Valk P. 2007. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 66:819-827.
31. Gilson J, Blakemore WF. 1993. Failure of remyelination in areas of demyelination produced in the spinal cord of old rats. Neuropathol Appl Neurobiol 19:173-181.
32. Grinberg YY, Milton JG, Kraig RP. 2011. Spreading depression sends microglia on Levy flights. PLoS One 6:e19294.
33. Grinberg YY, Dibbern ME, Levasseur VA, Kraig RP. 2013. Insulin-like growth factor-1 abrogates microglial oxidative stress and the TNF-α responses to spreading depression. J Neurochem 126:662-672.
34. Guy J, Ellis EA, Hope GM, Emerson S. 1991. Maintenance of myelinated fibre g ratio in acute experimental allergic encephalomyelitis. Brain 114:281-294.
35. Haber M, Vautrin S, Fry EJ, Murai KK. 2009. Subtype-specific oligodendrocyte dynamics in organotypic culture. Glia 57:1000-1013.
36. Hailer NP, Jarhult JD, Nitsch R. 1996. Resting microglial cells in vitro: Analysis of morphology and adhesion molecule expression in organotypic hippocampal slice cultures. Glia 18:319-331.
37. Hulse RE, Swenson WG, Kunkler PE, White DM, Kraig RP. 2008. Monomeric IgG is neuroprotective via enhancing microglial recycling endocytosis and TNF-alpha. J Neurosci 25:3952-3961.
38. Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, Lassmann H, Wekerle H, Hohlfeld R, Meinl E. 2009. MicroRNA profiling of multiple sclerosis lesions idendifies modulators of the regulatory protein CD47. Brain 132:3342-3352.
39. + CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration. Neuron 68:668-681.
40. Keough MB, Yong VW. 2012. Remyelination therapy for multiple sclerosis. Neurotherapeutics 10:44-54.
41. Knerlich-Lukoschus F, von der Ropp-Brenner B, Lucius R, Mehdorn HM, Held-Feindt J. 2010. Chemokine expression in the white matter spinal cord precursor niche after force-defined spinal cord contusion injuries in adult rats. Glia 58:916-931.
42. Kuhlmann T, Mirion V, Cui Q, Wegner C, Antel J, Bruck W. 2008. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131:1749-1758.
43. Kunkler PE, Kraig RP. 1997. Reactive astrocytosis from excitotoxic injury in hippocampal organ culture parallels that seen in vivo. J Cereb Blood Flow Metab 17:26-43.
44. Kunkler PE, Hulse RE, Kraig RP. 2004. Multiplexed cytokine protein expression profiles from spreading depression in hippocampal organotypic cultures. J Cereb Blood Flow Metab 24:829-839.
45. Lassmann H, Bruck W, Lucchinetti C, Rodriguez M. 1997. Remyelination in multiple sclerosis. Mult Scler 3:133-136.
46. Li JS, Yao ZX. 2012. MicroRNAs: Novel regulators of oligodendrocyte differentiation and potential therapeutic targets in demyelination-related diseases. Mol Neurobiol 45:200-212.
47. Liang Y, Ridzon D, Wong L, Chen C. 2007. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8:166.
48. Lin W, Kunkler PE, Harding HP, Ron D, Kraig RP, Popko B. 2008. Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gamma. Am J Pathol 173:1508-1517.
49. Liu XF, Fawcett JR, Thorne RG, DeFor TA, Frey WH. 2001. Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage. J Neurol Sci 187:91-97.
50. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
51. Mitchell HM, White DM, Domowicz MS, Kraig RP. 2011. Cold pre-conditioning neuroprotection depends on TNF-α and is enhanced by blockade of interleukin-11. J Neurochem 117:187-196.
52. Montecalvo A, Larregina AT, Shufesky WJ, Stolz DB, Sullivan ML, Karlsson JM, Baty CJ, Gibson GA, Erdos G, Wang Z, Milosevic J, Tkacheva OA, Divito SJ, Jordan R, Lyons-Weiler J, Watkins SC, Morelli AE. 2012. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119:756-766.
53. Multiple Sclerosis Therapy Consensus Group (MSTCG), Wiendl H, Toyka KV, Riekmann P, Gold R, Hartung HP, Hohlfeld R. 2008. Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations. J Neurol 255:1449-1463.
54. Nave KA. 2010. Oligodendrocytes and the "micro brake" of progenitor cell proliferation. Neuron 65:577-579.
55. Nishiyama A, Lin XH, Giese N, Heldin CH, Stallcup WB. 1996. Co-localization of NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells in the developing rat brain. J Neurosci Res 43:299-314.
56. Obiang P, Maubert E, Bardou I, Nicole O, Launay S, Bezin L, Vivien D, Agin V. 2011. Enriched housing reverses age-associated impairment of cognitive functions and tPA-dependent maturation of BDNF. Neurobiol Learn Mem 96:121-129.
57. O'Loughlin AJ, Woffindale CA, Wood MJ. 2012. Exosomes and the emerging field of exosome-based gene therapy. Curr Gen Ther 12:262-274.
58. Penderis J, Shields SA, Franklin RJ. 2003. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain 126:1382-1391.
59. Ponomarv ED, Veremeyko T, Weiner HL. 2013. MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia 61:91-103.
60. Pusic AD, Kraig RP. 2010. Inflammatory gene micro array profiling demonstrates "T-cell-like" activation after recurrent spreading depression - implications for migraine pathogenesis. Soc Neurosci 36:Prog#346.3.
61. Pusic AD, Grinberg YY, Mitchell HM, Kraig RP. 2011. Modeling neural immune signaling of episodic and chronic migraine using spreading depression in vitro. J Vis Exp (52):2910.
62. Pusic AD, Kraig RP. 2012. Exosome-mediated mitigation of oxidative stress and demyelination. Soc Neurosci 38:Prog#157.01.
63. Raineteau O, Rietschin L, Gradwohl G, Guillemot F, Gahwiler BH. 2004. Neurogenesis in hippocampal slice cultures. Mol Cell Neurosci 26:241-250.
64. Ransohoff RM, Perry VH. 2009. Microglial physiology: Unique stimuli, specialized responses. Annu Rev Immunol 28:119-145.
65. Rist JM, Franklin RJ. 2008. Taking aging into account in remyelination-based therapies for multiple sclerosis. J Neurol Sci 274:64-67.
66. Ruckh JM, Ahao JW, Shadrach JL, van Wijngaarden P, Rao TN, Wagers AJ, Franklin RJ. 2012. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 10:96-103.
67. Schorey JS, Shin JY, McManus MT, Ptacek LJ, Fu YH. 2009. Dicer ablation in oligodendrocytes provokes neuronal impairment in mice. Ann Neurol 66:843-857.
68. Shin D, Shin JY, McManus MT, Ptacek LJ, Fu YH. 2009. Dicer ablation in oligodendrocytes provokes neuronal impairment in mice. Ann Neurol 66:843-857.
69. Sim FJ, Zhao C, Pendris J, Franklin RJ. 2002. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci 22:2451-2459.
70. Sommer I, Schachner M. 1981. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: An immunocytological study in the central nervous system. Dev Biol 83:311-327.
71. Sypecka J, Sarnowska A, Domanska-Janik K. 2009. Crucial role of the local micro-environment in fate decision of neonatal rat NG2 progenitors. Cell Prolif 27:2591-2601.
72. Woodruff RH, Fruttiger M, Richardson WD, Franklin RJ. 2004. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol Cell Neurosci 25:252-262.
73. Zhao X, He X, Han X, Yu Y, Ye F, Chen Y, Hoang T, Xu X, Li H, Wang F, Appel B, Lu RQ. 2010. MicroRNA-mediated control of oligodendrocyte differentiation. Neuron 65:612-626.
74. Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, Axtell RC, Ju S, Mu J, Zhang L, Steinmann L, Miller D, Zhang HG. 2011. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 19:1769-1779.